Literature DB >> 2450710

IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release.

B Gruber1, D Ballan, P D Gorevic.   

Abstract

IgE rheumatoid factor activity was found to be significantly elevated (P less than 0.01) using an ELISA assay when paired synovial fluid and sera from 13 patients with active RA were compared to ten control samples. Synovial fluid IgE RF activity was higher than predicted by diffusion alone in 7/11 (64%) of the RA synovial fluids studied when coefficients of diffusion were determined. The specificity of IgE RF activity as measured by the ELISA was confirmed using immunoaffinity chromatography. Mast cells, obtained by enzymatic dispersion of rheumatoid synovial tissue, were sensitized with sera containing either IgE antibodies directed against ragweed or IgE with RF activity. Histamine was released upon challenge with anti-IgE antibodies (33.2% +/- 11), ragweed antigen E (34.6% +/- 11), or aggregated gamma globulin (47.6% +/- 17.9). No histamine release was observed if antigen challenge occurred in the absence of appropriate sensitization, with C3 anaphylatoxin, or after immunoadsorption of IgE from sera containing IgE RF activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450710      PMCID: PMC1541432     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

Review 1.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

2.  Letter: Basophils and mast cells in renal allograft rejection.

Authors:  R B Colvin; H F Dvorak
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

3.  Disease distribution of synovial fluid mast cells and cytophagocytic mononuclear cells in inflammatory arthritis.

Authors:  A J Freemont; J Denton
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

4.  Mast-cell degranulation in Crohn's disease.

Authors:  A M Dvorak; R A Monahan; J E Osage; G R Dickersin
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

5.  Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis.

Authors:  G G Hunder; G J Gleich
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

6.  Histologic studies of chronic idiopathic urticaria.

Authors:  S F Natbony; M E Phillips; J M Elias; H P Godfrey; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1983-02       Impact factor: 10.793

7.  Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy.

Authors:  D G Malone; R L Wilder; A M Saavedra-Delgado; D D Metcalfe
Journal:  Arthritis Rheum       Date:  1987-02

8.  Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases.

Authors:  B L Zuraw; C H O'Hair; J H Vaughan; D A Mathison; J G Curd; D H Katz
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

9.  Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

Authors:  R A Hawkins; H N Claman; R A Clark; J C Steigerwald
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

10.  STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

Authors:  L M LICHTENSTEIN; A G OSLER
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

View more
  6 in total

1.  Suppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies.

Authors:  S Yoshino; M Sasahara; Pilaiwanwadee Hutamekalin; K Yamaki; N Mizutani; H Kuramoto
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but not morphine sulfate.

Authors:  J W Verbsky; P K McAllister; D G Malone
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

Review 3.  Mast cells in inflammatory arthritis.

Authors:  Peter A Nigrovic; David M Lee
Journal:  Arthritis Res Ther       Date:  2004-11-02       Impact factor: 5.156

4.  Inhibition of inflammatory arthritis using fullerene nanomaterials.

Authors:  Anthony L Dellinger; Pierre Cunin; David Lee; Andrew L Kung; D Bradford Brooks; Zhiguo Zhou; Peter A Nigrovic; Christopher L Kepley
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

5.  Glycan and Peptide IgE Epitopes of the TNF-alpha Blockers Infliximab and Adalimumab - Precision Diagnostics by Cross-Reactivity Immune Profiling of Patient Sera.

Authors:  Arne Homann; Niels Röckendorf; Arno Kromminga; Andreas Frey; Thomas A Platts-Mills; Uta Jappe
Journal:  Theranostics       Date:  2017-10-17       Impact factor: 11.556

6.  Effects of rheumatoid arthritis associated transcriptional changes on osteoclast differentiation network in the synovium.

Authors:  Shilpa Harshan; Poulami Dey; Srivatsan Ragunathan
Journal:  PeerJ       Date:  2018-10-11       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.